The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients

ConclusionsTherapeutic regimens of IFN- α + lopinavir/ritonavir and IFN-α + lopinavir/ritonavir + ribavirin might be beneficial for treatment of COVID-19. Serum LDH or CK decline may predict a favorable response to treatment of COVID-19 infection.

Source: Inflammation Research - March 28, 2020 Category: Research Source Type: research